Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
32,553,745
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
20,845,367
-
Shares change
-
-1,559,296
-
Total reported value, excl. options
-
$45,026,701
-
Value change
-
-$4,167,716
-
Put/Call ratio
-
156%
-
Number of buys
-
37
-
Number of sells
-
38
-
Price
-
$2.16
Institutional Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) as of Q1 2025
As of 31 Mar 2025 Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,845,367 shares of stock of the company.
Largest 10 holders included Alpha Wave Global, LP, ARMISTICE CAPITAL, LLC, BlackRock, Inc., FMR LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Vestal Point Capital, LP, AWM Investment Company, Inc., and MARSHALL WACE, LLP.
This table shows 83 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.